实用医药杂志
實用醫藥雜誌
실용의약잡지
Practical Journal of Medicine & Pharmacy
2015年
4期
325-327
,共3页
余晓红%吕宏迪%郑颖娟%谢琳
餘曉紅%呂宏迪%鄭穎娟%謝琳
여효홍%려굉적%정영연%사림
恶性肿瘤%乙型肝炎病毒%HBV-M%HBV DNA
噁性腫瘤%乙型肝炎病毒%HBV-M%HBV DNA
악성종류%을형간염병독%HBV-M%HBV DNA
Malignant tumor%Hepatitis B virus%HBV-M%HBV DNA
目的:探讨恶性肿瘤患者乙型肝炎病毒(HBV)血清标志物(HBV-M)和HBV DNA检测结果及临床意义。方法采用化学发光免疫分析和荧光定量PCR方法,对所有病例及对照组进行HBV-M和HBV DNA检测。结果405例各种恶性肿瘤患者HBV-M阳性共185例,阳性率为45.7%,HBV DNA检出率大三阳组为100%(19/19),小三阳组为60.0%(15/25),二者比较具有显著性的统计学意义(P<0.05)。肝癌患者的阳性率最高,达89.2%;其次为胃、食管、直肠癌,其阳性率分别为48.9%、45.5%、45.2%;白血病为35.8%;肺、鼻咽癌分别为32.4%、25.0%;(恶性)淋巴瘤、甲状腺癌、宫颈癌的阳性率分别为32.0%、28.8%、23.8%。与对照组比较,差异有统计学意义(P<0.01),恶性消化道肿瘤患者HBV感染的阳性率与其他系统恶性肿瘤患者相比明显偏高(P<0.05)。结论恶性肿瘤患者的HBV感染阳性率高,其中消化道恶性肿瘤的HBV感染阳性率最高。
目的:探討噁性腫瘤患者乙型肝炎病毒(HBV)血清標誌物(HBV-M)和HBV DNA檢測結果及臨床意義。方法採用化學髮光免疫分析和熒光定量PCR方法,對所有病例及對照組進行HBV-M和HBV DNA檢測。結果405例各種噁性腫瘤患者HBV-M暘性共185例,暘性率為45.7%,HBV DNA檢齣率大三暘組為100%(19/19),小三暘組為60.0%(15/25),二者比較具有顯著性的統計學意義(P<0.05)。肝癌患者的暘性率最高,達89.2%;其次為胃、食管、直腸癌,其暘性率分彆為48.9%、45.5%、45.2%;白血病為35.8%;肺、鼻嚥癌分彆為32.4%、25.0%;(噁性)淋巴瘤、甲狀腺癌、宮頸癌的暘性率分彆為32.0%、28.8%、23.8%。與對照組比較,差異有統計學意義(P<0.01),噁性消化道腫瘤患者HBV感染的暘性率與其他繫統噁性腫瘤患者相比明顯偏高(P<0.05)。結論噁性腫瘤患者的HBV感染暘性率高,其中消化道噁性腫瘤的HBV感染暘性率最高。
목적:탐토악성종류환자을형간염병독(HBV)혈청표지물(HBV-M)화HBV DNA검측결과급림상의의。방법채용화학발광면역분석화형광정량PCR방법,대소유병례급대조조진행HBV-M화HBV DNA검측。결과405례각충악성종류환자HBV-M양성공185례,양성솔위45.7%,HBV DNA검출솔대삼양조위100%(19/19),소삼양조위60.0%(15/25),이자비교구유현저성적통계학의의(P<0.05)。간암환자적양성솔최고,체89.2%;기차위위、식관、직장암,기양성솔분별위48.9%、45.5%、45.2%;백혈병위35.8%;폐、비인암분별위32.4%、25.0%;(악성)림파류、갑상선암、궁경암적양성솔분별위32.0%、28.8%、23.8%。여대조조비교,차이유통계학의의(P<0.01),악성소화도종류환자HBV감염적양성솔여기타계통악성종류환자상비명현편고(P<0.05)。결론악성종류환자적HBV감염양성솔고,기중소화도악성종류적HBV감염양성솔최고。
Objective To investigate hepatitis B virus (HBV) markers in the malignant tumor patients serum (HBV-M) and HBV DNA detection results and their clinical significance. Methods Chemiluminescence immunoassay and fluorescence quantitative PCR method were used in detection of the patients and control group in HBV-M and HBV DNA. Results In 405 patients with HBV-M positive,were 185 cases of malignant tumor, the positive rate was 45.7%;HBV DNA positive rate of HBeAg group was 100%(19/19);Small "Sanyang" group was 60%(15/25),Statistical significance among the two groups was significant (P<0.05). The positive rate of liver cancer patients was with the highest,up to 89.2%;Secondary,esophageal,gastric cancer,i.e positive rates were 48.9%,45.5%,45.2%;Leukemia was 35.8%; lung,nasopharyngeal carcinoma were 32.4%,25%;(malignant),the positive rate of lymphoma of thyroid cancer,cervical cancer were 32%,28.8%,23.8% respectively. Compared with the control group,the difference was statistically significant (P<0.01),malignant tumor of digestive tract in patients infected with HBV positive rate is significantly higher than patients with other malignant tumors (P<0.05). Conclusion HBV in patients with malignant tumor infection positive rate is high,the malignant tumor of digestive tract HBV infection positive rate is the highest.